Philly.com -- A Pfizer Inc. unit's menopause drug was not a cause of a woman's breast cancer, and the drugmaker is not liable for damages, a Philadelphia jury found yesterday. In a similar case, a jury here Monday had found against Pfizer and ordered nearly $10 million in damages.
